atenolol and olmesartan

atenolol has been researched along with olmesartan in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ekins, S; Williams, AJ; Xu, JJ	1
Averill, DB; Brosnihan, KB; Ferrario, CM; Schiffrin, EL; Smith, RD; Yokoyama, H	1
Agabiti-Rosei, E; Laeis, P; Ludwig, M; Scholze, J; Schremmer, D; Schwandt, P; Stumpe, KO; Zielinski, T	1
Brown, I; Gallivan, C	1

Trials

1 trial(s) available for atenolol and olmesartan

Article	Year
Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study. Therapeutic advances in cardiovascular disease, 2007, Volume: 1, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Atenolol; Carotid Arteries; Carotid Artery Diseases; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Pilot Projects; Tetrazoles; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography	2007

Article

Year

Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study.

Therapeutic advances in cardiovascular disease, 2007, Volume: 1, Issue:2

Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Atenolol; Carotid Arteries; Carotid Artery Diseases; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Pilot Projects; Tetrazoles; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography

2007

Other Studies

4 other study(ies) available for atenolol and olmesartan

Article	Year
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy. American journal of hypertension, 2005, Volume: 18, Issue:7 Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiomegaly; Collagen; Disease Progression; Endothelium, Vascular; Heart Rate; Hypertension; Imidazoles; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Vascular Diseases; Vascular Resistance	2005
[Lowering blood pressure and more? AT1 antagonist reduced plaque volume]. MMW Fortschritte der Medizin, 2008, May-01, Volume: 150, Issue:18 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Atenolol; Blood Pressure; Carotid Stenosis; Humans; Hypertension; Imidazoles; Randomized Controlled Trials as Topic; Tetrazoles	2008
Olmesartan induced enterocolitis. Pathology, 2014, Volume: 46, Issue:4 Topics: Aged; Amitriptyline; Anticholesteremic Agents; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Atenolol; Atorvastatin; Dihydropyridines; Enterocolitis; Female; Heptanoic Acids; Humans; Imidazoles; Pyrroles; Tetrazoles	2014